Nebuliser solution: Clear, colourless or almost colourless liquid, free from suspended particles.
1 mL (20 drops) nebuliser solution contains 261mcg (8r)-3α-hydroxy-8-isopropyl-1αH,5αH-tropanium bromide (±)-tropate monohydrate (= ipratropium bromide monohydrate) corresponding to 250 mcg ipratropium bromide anhydrous.
Inhalation solution: Clear, colourless or almost colourless liquid, free from suspended particles.
500 mcg/2 mL: 1 unit dose vial (1 or 2 ml) solution for inhalation contains 522 mcg (8r)-3α-hydroxy-8-isopropyl-1αH,5αH-tropanium bromide (±)-tropate monohydrate (= ipratropium bromide monohydrate) corresponding to 500 mcg ipratropium bromide anhydrous.
Excipients/Inactive Ingredients: Nebuliser solution: benzalkonium chloride, disodium edetate dihydrate, sodium chloride, hydrochloric acid, purified water.
Inhalation solution: sodium chloride, hydrochloric acid, purified water.